NDCHealth Announces Early Termination of HSR Waiting Period
29 Septembre 2005 - 4:01PM
PR Newswire (US)
ATLANTA, Sept. 29 /PRNewswire-FirstCall/ -- NDCHealth Corporation
(NYSE:NDC) today announced it has received notification of early
termination of the waiting period under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976 (HSR) with respect to the
proposed sale of NDCHealth's information management business to
Wolters Kluwer (ASE:WKL) as well as Per-Se Technologies'
(NASDAQ:PSTI) proposed acquisition of NDCHealth. As previously
announced, the companies signed definitive agreements pertaining to
these transactions, which, subject to approval by both NDCHealth
and Per-Se shareholders and other customary closing conditions, are
anticipated to close three to six months from signing. NDCHealth is
a leading information solutions company serving all sectors of
healthcare. Its network solutions automate the exchange of
information among pharmacies, payers, hospitals and physicians. Its
systems and information management solutions help improve
operational efficiencies and business decision making for
providers, retail pharmacy and pharmaceutical manufacturers.
Headquartered at Atlanta, Ga., NDCHealth provides information vital
to the delivery of healthcare every day. For more information,
please visit http://www.ndchealth.com/ Important Legal Information
This communication is being made in respect of the proposed
acquisition transaction involving NDCHealth Corporation and Per-Se
Technologies. This communication shall not constitute an offer of
any securities for sale. In connection with the proposed
transaction, NDCHealth and Per-Se have filed a registration
statement on Form S-4 containing a preliminary joint proxy
statement/prospectus for the stockholders of both companies with
the SEC, and each will be filing other documents regarding the
proposed transactions with the SEC as well. Before making any
voting or investment decision, investors are urged to read the
preliminary joint proxy statement/prospectus regarding the proposed
transactions and any other relevant documents carefully in their
entirety when they become available, as well as any amendments and
supplements thereto, as they will contain important information
about the proposed transaction. The final joint proxy
statement/prospectus will be mailed to the shareholders of both
NDCHealth and Per-Se. You may obtain copies of all documents filed
with the SEC regarding this transaction, free of charge, at the
SEC's website (http://www.sec.gov/). You may also obtain these
documents, free of charge, from NDCHealth's website
(http://www.ndchealth.com/) under the tab "Investor Relations"
through the "SEC Filing" link. You may also obtain these documents,
free of charge, from Per- Se's website (http://www.per-se.com/)
under the tab "Investors" through the "SEC Filing" link. NDCHealth
Corporation and Per-Se Technologies and their respective directors
and executive officers may be deemed participants in the
solicitation of proxies from stockholders in connection with this
transaction. Information about the directors and executive officers
of NDCHealth and Per-Se Technologies and information about other
persons who may be deemed participants in this transaction will be
included in the joint proxy statement/prospectus. You can find
information about NDCHealth's executive officers and directors in
NDCHealth's Form 10-K/A filed with the SEC on September 14, 2005.
You can find information about Per-Se Technologies' executive
officers and directors in Per-Se's definitive proxy statement filed
with the SEC on March 25, 2005. DATASOURCE: NDCHealth Corporation
CONTACT: Robert P. Borchert, VP-Investor Relations of NDCHealth
Corporation, +1-404-728-2906, or Web site:
http://www.ndchealth.com/ http://www.per-se.com/
Copyright
Ndchealth (NYSE:NDC)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Ndchealth (NYSE:NDC)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Ndchealth Corp (New York Stock Exchange): 0 recent articles
Plus d'articles sur Ndchealth Corp